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Global and regional left ventricular (LV) systolic dysfunction is a marker of coronary artery disease (CAD), which is
conventionally assessed using two-dimensional echocardiography. Tissue Doppler imaging (TDI) has emerged as an
adjunct tool in the diagnosis of regional wall motion abnormalities from CAD. We performed a systematic review
and meta-analysis to assess the efficacy of TDI indices in the diagnosis of CAD. We searched MEDLINE and the
Cochrane Library for controlled studies comparing TDI measurements in those with and without CAD as confirmed
by coronary angiography. Meta-analyses of mean differences in TDI velocities between these populations were
performed. Screening of titles and abstracts followed by full-text screening identified 8 studies. At rest, TDI was
associated with a significant decrease in the pooled maximum systolic velocity among CAD patients compared to
those without CAD [mean difference (MD): -0.66; 95% confidence interval (CI): -0.98 to −0.34]. There were no
significant differences in maximum early and late diastolic velocities. Post-stress, TDI was associated with a
significant decrease in maximum early diastolic velocity (MD: -1.91; 95% CI: -2.74 to −1.09) and maximum late
diastolic velocity (MD: -1.57; 95% CI: -2.95 to −0.18) among CAD patients compared to those without CAD. There
was no significant difference in maximum systolic velocity post-stress. Our results suggest that TDI may have a role
in the evaluation of CAD. Future studies should evaluate the incremental value of TDI velocities over LV ejection
fraction and two dimensional wall motion analysis in the detection of CAD and assessment of its severity. (Word
Count: 249)
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Coronary artery disease (CAD) is responsible for one out
of every six deaths in the United States. Each year, approxi-
mately 800,000 Americans have a new coronary event
resulting in approximately one death per minute [1]. This
extraordinary burden of disease necessitates early diagnosis
and treatment.
Non-invasive imaging tests like radionuclide imaging
and stress echocardiography are frequently used in clinical
practice for detection and evaluation of CAD [2]. Global
and regional left ventricular (LV) systolic function is an
important marker of CAD in stress echocardiography,* Correspondence: rajender.agarwal@gmail.com
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reproduction in any medium, provided the orwhich is conventionally assessed using two-dimensional
echocardiography. In 1989, the technique of tissue Doppler
imaging (TDI) emerged as a potential modality for
assessing systolic and diastolic LV performance [3-5].
TDI visualizes myocardial velocities by measuring low-
frequency, high-amplitude signals of myocardial motion.
TDI is done using either the spectral pulsed-wave or the
color-coded pulsed-wave technique. Spectral Doppler
measures the instantaneous velocity in a sample volume
of the region of interest, while color-coded Doppler
allows simultaneous sampling of the entire ultrasound
sector [6-8].
Most of the studies of TDI have employed the technique
for measuring LV diastolic function. Other investigators
have applied TDI to measure resting or post-stress veloci-
ties of various myocardial segments of the LV as an adjunctl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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from CAD. However, there has not been a consensus
on the value of these techniques in the diagnosis of
CAD. In this paper, we perform a systematic review
and meta-analysis to assess the efficacy of TDI indices
in the diagnosis of CAD.
Methods
Study selection
We searched MEDLINE (inception to June 2012) and the
Cochrane Library (inception to June 2012) using keywords
and/or medical subject headings (MeSH) for TDI and
CAD. The detailed search strategy for MEDLINE is pre-
sented in Table 1. Titles and abstracts of the references
identified were screened by a single reviewer. This was fol-
lowed by full-text review by two independent reviewers of
those articles meeting inclusion criteria. Disagreements
were resolved by consensus. We included in our analysis
all controlled trials that: 1) were published in English,
2) compared TDI measurements (spectral pulsed wave or
color-coded pulsed wave) in those with and without CAD
as confirmed by coronary angiography, and 3) evaluated at
least one of the following measurements - maximum
systolic velocity, maximum early diastolic velocity or
maximum late diastolic velocity.
Data extraction
We extracted data on study design, intervention, patient
population, size of the study sample, and our outcome
measures. The primary outcomes of interest were the
mean differences in the following variables as measured
by TDI in those with and without CAD: maximum sys-
tolic velocity, maximum early diastolic velocity, and
maximum late diastolic velocity. In addition we also
extracted data on mean differences in E/E' (the ratio of
early diastolic transmitral flow velocity and earlyTable 1 Search strategy for including studies
PHASE 1: SEARCH TERMS FOR TISSUE DOPPLER
1 tissue adj doppler
2 tissue adj velocity adj imaging
3 (TDI or TVI).mp.
4 or/1-3
PHASE 2: SEARCH TERMS FOR CORONARY ARTERY DISEASE
5 exp Coronary Artery Disease/
6 exp Atherosclerosis/
7 (coronary adj artery adj disease).mp.
8 CAD.mp.
9 or/5-8
PHASE 3: COMBINING THE SEARCHES AND RESTRICTING TO ENGLISH
10 4 and 9
11 limit 10 to english languagediastolic tissue velocity) and E'/A' (the ratio of early and
late diastolic tissue velocity) as measured by TDI in those
with and without CAD. For all outcomes, data was
extracted as means and standard deviations.
Statistical analyses
We performed meta-analyses of the included controlled
studies using the Mantel-Haenszel procedure that assumes
a fixed effect size [9]. We measured heterogeneity between
study results using the I2 statistic[10]. We defined signifi-
cant heterogeneity as an I2 statistic ≥ 50% which would
imply real differences between study results that would not
be explained by chance alone. In the presence of significant
heterogeneity, we performed additional meta-analyses using
the random-effects model that produces more conservative
estimates of effect [11]. The estimates used in our meta-
analyses were mean differences (MD) and 95% confidence
intervals (CI) in TDI measurements for our measures of
interest in those with and without CAD. Sensitivity analyses
were performed using only those studies that verified both
the presence and absence of CAD with angiography.
Results
Study selection
Our literature search initially yielded 330 references.
Screening of titles and abstracts followed by full-text
screening ultimately identified 8 studies [12-19] that met
our pre-defined inclusion criteria (Figure 1).
Study characteristics
Combined, the 8 studies included 568 patients. Details of
the study populations, segments in which TDI velocities
were studied and the echocardiography machine used are
shown in Table 2. No randomized controlled trials were
identified; all studies were prospective controlled studies.
CAD patients had significant disease confirmed by angiog-
raphy in all studies. Patients without significant CAD
either had no obstructive CAD on angiography or had
negative results on non-invasive stress testing.Figure 1 Flow diagram for selection of included studies.
Table 2 Study characteristics
Author,
Year (Reference)
Study design CAD (N) No CAD (N) Segments studied Type of tissue
doppler
Machine used
Bolognesi, 2001 [12] Prospective
controlled study
Stable effort angina without previous
MI and with normal EF, CAD confirmed
with angiography(16)
Negative noninvasive coronary stress
tests and normal electrocardiographic
and echocardiographic findings in
volunteers undergoing cardiac
catheterization (6)
Apical four chamber view:
septal and anterolateral
Not reported Toshiba 380,
Rome, Italy
Apical two chamber view:
anterior and inferior
Bruch, 1999 [13] Prospective
controlled study
CAD on angiogram (>70% LAD), no
previous MI or cardiac surgery and
no echo evidence of regional or
global wall motion abnormalities (17)
Normal resting electrocardiogram and
a normal regional and global systolic left
ventricular function on echocardiogram (20)






Dounis, 2006 [14] Prospective
controlled study
1-2 vessel disease, confirmed by
angiogram, normal EF and sinus
rhythm (17)
No CAD confirmed by either angiogram
or stress testing, normal EF and sinus
rhythm(14)








Hoffmann, 2010 [15] Prospective
controlled study
Significant one, two or three vessel
disease included. (47)
Suspected angina pectoris and non









Madler, 2003 [16] Prospective
controlled study
Significant stenosis (>50%) on coronary
angiography (90)
Chest pain with no significant stenosis
(<50%)on coronary angiography (59)
Apical four and two chamber
view: basal septal, basal anterior,
basal lateral and basal inferior
and mid septal, mid anterior,






Tsougos, 2008 [17] Prospective
controlled study
Stenosis >70% of at least one coronary
artery (72)







Williams, 2005 [18] Prospective
controlled study
Angiography confirmed >50% stenosis
in at least one major coronary artery
branch; chronic stable symptoms and
normal resting global/regional LV
function assessed by left ventriculography
and echocardiography (16)
Normal coronary angiography; negative,
maximum, Bruce protocol exercise testing,










Zagatina, 2007 [19] Prospective
controlled study
Significant stenosis in the LAD on
angiography (88)
Normal angiogram (17) Long and short-axis parasternal
views and the four and two-
chamber apical views: basal and
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studies except one [19] and were assessed after stress
testing in 5 studies [14,16-19]. Among the latter, exercise
stress testing was performed in 3 studies ([17-19], dipyr-
idamole stress testing was performed in one study [14]
and dobutamine stress testing was performed in one
study [16]. Three studies reported data on E/E'
[12,13,17] and 4 studies on E'/A' [12-14,17].
Primary outcomes (Pre-stress)
TDI was associated with a significant decrease in
maximum systolic velocity among CAD patients when
compared to those without CAD (MD: -0.66; 95% CI:
-0.98 to −0.34). There was no significant heteroge-
neity among studies (I2 =46%) (Figure 2A). MaximumFigure 2 Meta-analysis: Primary outcomes (pre-stress).early diastolic velocity was significantly decreased
among CAD patients when compared to those with-
out CAD (MD: -0.46; 95% CI: -0.79 to −0.13). How-
ever, I2 was significant at 88%. When random-effects
meta-analysis was done, the mean difference between
those with and without CAD was not significant
(MD: -0.94; 95% CI: -2.02 to 0.14) (Figure 2B). TDI
was associated with a significant decrease in maxi-
mum late diastolic velocity among CAD patients
when compared to those without CAD (MD: -0.63;
95% CI: -1.04 to −0.23; I2 =77%). Because of the sig-
nificant heterogeneity, a random-effects meta-analysis
was performed which did not demonstrate a signifi-
cant difference (MD: -0.79; 95% CI: -1.72 to 0.13)
(Figure 2C).
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Meta-analysis demonstrated a significant decrease in
maximum systolic velocity among CAD patients
when compared to those without CAD (MD: -1.90;
95% CI: -2.69 to −1.11). There was significant heterogeneity
(I2 =90%). Differences between patients with and
without CAD were not statistically significant with a
random-effects meta-analysis (MD: -2.64; 95% CI: -5.47 to
0.19) (Figure 3A). TDI was associated with a significant
decrease in maximum early diastolic velocity among CAD
patients when compared to those without CAD (MD:
-1.91; 95% CI: -2.74 to −1.09; I2 =0%) (Figure 3B).
Maximum late diastolic velocity was also significantly
decreased among CAD patients when compared to those
without CAD (MD: -1.54; 95% CI: -2.33 to −0.75). A
random-effects meta-analysis was performed because of
significant heterogeneity (I2 =66%), and the mean diffe-
rence between patients with and without CAD remainedFigure 3 Meta-analysis: Primary outcomes (post-stress).statistically significant (MD: -1.57; 95% CI: -2.95 to −0.18)
(Figure 3C).Sensitivity analyses
Meta-analyses using only those studies that verified both
the presence and absence of CAD with angiography
showed similar results as the primary analyses. However,
there was decreased heterogeneity for the outcome of
maximum late diastolic velocity both pre- and post-stress.
Additionally, maximum systolic velocity was significantly
decreased among CAD patients when compared to those
without CAD post-stress, although heterogeneity was still
significant (Table 3).Secondary outcomes
There was not a statistically significant mean difference
between E/E' or E'/A' measurements using TDI among
Table 3 Summary table with pooled results
Outcome Primary analysis* Sensitivity analysis of studies using angiography











Pooled Results – MD
(95% CI); I2
Pre-stress
Maximum systolic velocity 5 200 −0.66 (−0.98 to −0.34); 46% 3 132 −0.54 (−0.91 to −0.17); 44%
Maximum early diatolic velocity 6 314 −0.94 (−2.02 to 0.14); 88% 4 246 −0.89 (−2.52 to 0.74); 89%
Maximum late diastolic velocity 6 314 −0.79 (−1.72 to 0.13); 77% 4 246 −0.13 (−0.61 to 0.35); 0%
Post-stress
Maximum systolic velocity 3 164 −2.64 (−5.47 to 0.19); 90% 2 133 −3.66 (−7.23 to −0.10); 87%
Maximum early diatolic velocity 3 173 −1.91 (−2.74 to −1.09); 0% 2 142 −1.45 (−2.53 to −0.38); 0%
Maximum late diastolic velocity 3 173 −1.57 (−2.95 to −0.18); 66% 2 142 −2.30 (−3.32 to −1.28); 0%
Abbreviations: CI confidence interval, MD mean difference.
* Fixed-effects model when I2 < 50% and random-effects model when I2 ≥ 50%.
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(Figure 4).
Discussion
To our knowledge, this is the first systematic review and
meta-analysis on the use of TDI for the evaluation of
CAD. Our results demonstrated significant differences
in TDI measurements in those with and without CAD,
including significant decreases in the maximum systolic
velocity pre-stress, and maximum early diastolic velocity
and maximum late diastolic velocity post-stress.
A correlation between decreased systolic velocity and
reduced regional myocardial blood flow has also been
demonstrated in animal models [20] and a decreasedFigure 4 Meta-analysis: Secondary outcomes.maximum systolic velocity is highly sensitive and specific
for detection of abnormal segmental myocardial motion
[21]. In contrast, relatively little data is available specific
to maximum early and late diastolic velocities. However,
one study demonstrated that reduction of early diastolic
velocity was more accurate than maximum systolic velo-
city for detection of CAD during dobutamine stress
echocardiography [22]. A formal evaluation of the test
characteristics (sensitivity, specificity, positive and nega-
tive predictive value) of TDI was not done because the
studies reporting these were done in disparate patient
population and used different indices of TDI [23-28].
Our results suggest that decreases in maximal systolic
velocity using TDI could be used to detect CAD in
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dimensional endocardial definition. It could be incorpo-
rated into an echocardiogram based CAD diagnostic
score, perhaps combined with wall motion score index,
to improve the detection of CAD. Wall motion analysis
is qualitative, and the addition of TDI adds a quantita-
tive component in the detection of CAD, theoretically
leading to improved intra- and inter-reader variability.
Although not addressed by these data, abnormal veloci-
ties may also signal a more severe degree of CAD than
suggested by wall motion analysis alone [29,30].
Measurement of diastolic velocities could also be incor-
porated into stress testing algorithms, particularly dobuta-
mine stress echocardiography, in which there is time to
measure both two-dimensional and TDI parameters. In the
ischemic cascade [31], diastolic dysfunction occurs earlier
than systolic dysfunction and thus measurement of
diastolic velocities by TDI may prove more sensitive
than wall motion analysis alone in the detection of CAD
during stress testing.
However, the cutoff values for maximum systolic velo-
city and diastolic velocities which detect CAD are, as
yet, unclear. Furthermore, TDI velocity can only be mea-
sured in one dimension and is significantly limited by
angle dependence, complicating assessment of multiple
wall segments (especially more apical segments). The ab-
sence of difference in the maximum systolic velocity
post-stress with TDI may be a result of this limitation.
Speckle tracking is a new technique that measures myo-
cardial motion in every direction, thus overcoming the
limitation of angle dependency and reliably quantifying
myocardial ischemia in both infarcted and non-infarcted
patients [32,33]. TDI velocities are also influenced by
tethering and translation, movement of other adjacent
structures and blood flow. Despite these limitations, the
American Society of Echocardiography/European Asso-
ciation of Echocardiography guidelines acknowledge that
TDI has major advantages like ready availability and
quantitative evaluation through online measurement of
velocities and time intervals [34].
The conclusions of our meta-analysis are limited by the
quality and relatively small number of included studies.
Another limitation is the significant heterogeneity observed
in the meta-analyses of maximum early and late diastolic
velocity (pre-stress); and maximum systolic velocity and
late diastolic velocity (post-stress). The heterogeneity could
be the result of subtle differences in patient populations,
segments in which TDI velocities were measured, models
of the echocardiography machines used in the assessments,
or type of tissue Doppler used (spectral Doppler, which
measures the instantaneous velocity, versus color Doppler
which measures the modal velocity). The methods of stress
testing used (e.g., dipyridamole vs. dobutamine) to diag-
nose CAD were different in the included studies andpresent an intrinsic limitation in interpreting the analyses.
Sensitivity analyses examining only those studies where
CAD was evaluated using angiography showed a reduction
in heterogeneity in some analyses (Table 3), suggesting that
the method used to diagnosis CAD in the studies may have
contributed to the observed heterogeneity. A third limita-
tion is that data on head-to-head comparisons between
TDI and other non-invasive imaging modalities or wall
motion score analysis for diagnosing CAD are not avai-
lable. It is thus unclear whether TDI has incremental value
for diagnosing CAD when compared with resting (or
stress) wall motion abnormalities or EKG abnormalities.
However, resting wall motion abnormalities and EKG ab-
normalities are relatively insensitive for detection of CAD,
so TDI may be helpful in improving the sensitivity of these
tests. Another limitation is that coronary angiography was
not performed in all patients across the studies. However,
sensitivity analyses that excluded such studies showed
similar meta-estimates. There may also be differences in
the proportions of patients with variables like hypertension
and left ventricular hypertrophy (LVH) across the studies
included in this systematic review, and these differences
could account for at least some of the heterogeneity
observed across studies in the test characteristics of TDI
for diagnosing CAD, as well as differences across studies in
E/E' or E'/A' measurements.TDI would be low in patients
with LVH or hypertension, potentially leading to false posi-
tives in patients with hypertension or LVH who do not
have CAD. Thus, if the proportion of these patients dif-
fered across studies, then the test characteristics of TDI for
diagnosing CAD might differ as a result. The proportion of
patients with hypertension ranged from 21% to 58% across
the included studies which could account for some of the
observed heterogeneity in the test characteristics of TDI
for diagnosing CAD. The proportion of patients with LVH
was not reported in any study. A final limitation is that
none of the above studies examined clinical outcomes, like
symptomatic CAD.
In conclusion, our results suggest that TDI has a
role in the evaluation of CAD. Future studies should
evaluate the incremental value of TDI systolic and
diastolic velocities over LV ejection fraction and two
dimensional wall motion analysis in the detection of CAD
and assessment of its severity.
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